Treatment of Ringworm (Tinea Infection)
For ringworm (tinea) infections, oral therapy with griseofulvin or terbinafine is recommended as first-line treatment, with the specific agent chosen based on the causative organism. 1, 2
Diagnosis
- Accurate diagnosis is essential before starting treatment - identification should be made either by direct microscopic examination of infected tissue in potassium hydroxide solution or by culture on appropriate medium 2
- In high-risk populations or when clinical features are highly suggestive (scaling, lymphadenopathy, alopecia), treatment may be initiated before culture results are available 1
Treatment Approach
Topical Therapy
- Topical therapy alone is not recommended for tinea capitis (scalp ringworm) 1
- For tinea corporis (body), tinea cruris (groin), and tinea pedis (feet), topical antifungal agents are often effective as first-line treatment 3, 4
- Common topical agents include:
- Azoles (clotrimazole, miconazole)
- Allylamines (terbinafine, naftifine)
- Treatment duration: 2 weeks for tinea corporis/cruris, 4 weeks for tinea pedis 4
Oral Therapy
For Tinea Capitis:
Griseofulvin:
Terbinafine:
For Extensive Tinea Corporis/Cruris:
- Oral therapy is indicated when infection is widespread or adjacent to eyes, ears, or mouth 5
- Options include:
Treatment Selection Algorithm
Identify the type of tinea infection:
- Tinea capitis (scalp) - requires oral therapy
- Tinea corporis/cruris/pedis - topical therapy for limited disease, oral for extensive disease
For tinea capitis:
- If Microsporum species or unknown: Griseofulvin for 6-8 weeks
- If Trichophyton species: Terbinafine for 2-4 weeks
For tinea corporis/cruris/pedis:
- Limited disease: Topical azole or allylamine
- Extensive disease: Oral therapy as outlined above
Adjunctive Measures
- For tinea capitis, topical antifungal shampoos (ketoconazole 2%, selenium sulfide 1%) can help reduce transmission of spores 1
- General hygiene measures should be observed to control sources of infection or reinfection 2
- For tinea capitis due to T. tonsurans, screening of family members and close contacts is warranted 1
Treatment Failure Considerations
- Ensure correct diagnosis was made initially
- Consider lack of compliance, suboptimal absorption, or relative insensitivity of the organism 1
- For clinical improvement but ongoing positive mycology, continue current therapy for 2-4 more weeks 1
- If no clinical improvement, switch to second-line therapy:
- If initial treatment was griseofulvin, switch to terbinafine for Trichophyton infections
- If initial treatment was terbinafine, switch to griseofulvin for Microsporum infections
- Itraconazole (5 mg/kg/day for 2-4 weeks) can be used as an alternative 1
Important Caveats
- Treatment should continue until the infecting organism is completely eradicated as indicated by appropriate clinical or laboratory examination 2
- Clinical relapse will occur if medication is not continued until the organism is eradicated 2
- Oral antifungal drugs are not effective against bacterial infections, candidiasis, or other non-dermatophyte fungal infections 2
- The use of systemic antifungals is not justified for minor or trivial dermatophyte infections that will respond to topical agents alone 2